BV3:ETR
Bavarian Nordic A/S
€२४.९६
arrow_upward
+१.४६%(+०.३६) 1D
३० एप्रि, ५:३५:४० PM [GMT]+२ · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | किंमत | बदल | % बदल |
|---|
insights_autoBV3 साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
€२४.७६
उच्च
€२४.९६
कमी
€२४.७६
मार्केट कॅप
२.३४ अब्ज
सरासरी उलाढाल
२८७.००
उलाढाल
१.००
५२ आठवड्यांतील उच्चांक
€३२.७५
५२ आठवड्यांतील नीचांक
€२३.१८
कर्मचाऱ्यांची संख्या
२ ह
बातम्यांच्या स्टोरी
संपूर्ण वेबवरील स्रोतांकडून
MarketBeat
·
१३ मिनिटांपूर्वी
Nasdaq, Inc. $NDAQ Shares Acquired by Danske Bank A S
MarketBeat
·
२३ मिनिटांपूर्वी
Washington Trust Bancorp, Inc. (NASDAQ:WASH) Given Average Recommendation of "Hold" by Analysts
WSJ
·
४६ मिनिटांपूर्वी
S&P 500 Extends Longest Weekly Winning Streak Since Late 2024
Simply Wall Street
·
५३ मिनिटांपूर्वी
The Bull Case For Nasdaq (NDAQ) Could Change Following Strong Q1 Results And Fintech Pivot - Learn Why
प्रोफाइल
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination. Wikipedia
Bavarian Nordic A/S बद्दल
AI आशयामध्ये चुका असू शकतात. अधिक जाणून घ्या